Elsevier and CONsortium on Core Electronic Resources in Taiwan establish agreement supporting open access publishing for Taiwanese researchers

Elsevier, a global leader in research publishing and information analytics, and the CONsortium on Core Electronic Resources in Taiwan (CONCERT) – the negotiating body representing universities in Taiwan – have successfully reached an agreement which supports open access (OA) publishing for Taiwanese authors and continued reading access to Elsevier’s world-leading content on ScienceDirect.

The new agreement takes effect from January 2023 and is the first agreement in Taiwan to address CONCERT’s objective for a phased and sustainable transition to OA, alongside continued research access for researchers from CONCERT-affiliated institutions.

Dr. Bou-wen Lin, Director General of STPI, said: “CONCERT has considered the various possibilities and limitations of open access publishing to reach this migration agreement, which is diverse, equitable and inclusive. More importantly, it responds to Taiwan’s publishing and reading needs. In the meantime, the new agreement aims to encourage and support Taiwanese researchers in their participation of open research.”

Gemma Hersh, SVP of Global Academic & Government Sales, Elsevier, said: “We have worked closely with CONCERT and its member universities to understand their research and open access objectives, resulting in a framework that supports a broad set of reading and publishing needs. We are delighted to continue our longstanding partnership with Taiwanese institutions and will continue to support the priorities of the Taiwanese research community.”

As one of the fastest-growing open access publishers in the world, nearly all of Elsevier's 2,800 journals enable open access publishing, including 600 fully open access journals. We now support over 2,000 institutions globally to publish open access through transformative agreements. In 2021 Elsevier published 119,000 gold or pay-to-publish open access articles, an increase of more than 46% over 2020.

For more on how Elsevier supports open access, please visit our website.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.